Breaking News
May 28, 2018 - New consensus statement outlines evidence-based medical opinion on abusive head trauma
May 28, 2018 - E-Cigarettes Don’t Help Smokers Quit, But Cash Might
May 28, 2018 - New screening tool developed to assess tanning addiction
May 28, 2018 - Unhappy combination of alcohol, anger, and aggressive behavior
May 28, 2018 - Loyola survey identifies significant group of burn patients with elevated PTSD symptoms
May 28, 2018 - Cancer cells co-opt pain-sensing ‘wasabi receptor’ to survive oxidative stress
May 27, 2018 - New way of grouping atoms could herald novel materials, drugs and computers
May 27, 2018 - Less is more? Gene switch for healthy aging found
May 27, 2018 - Breast cancer survivors do not receive recommended level of screening after surgery
May 27, 2018 - Recommendations Developed for Managing Postpartum Pain
May 27, 2018 - Rheumatoid Arthritis (RA) | Arthritis Basics | Arthritis Types | Arthritis
May 27, 2018 - ‘Life support’ for transplant livers better than freezing: study
May 27, 2018 - Tree nut consumption linked to improved type 2 diabetes health
May 27, 2018 - Income and education gap causes racial differences in health behaviors, study shows
May 27, 2018 - Even at ‘Safe’ Levels, Air Pollution Puts Seniors at Risk
May 27, 2018 - Obstructive sleep apnea linked to thinning of calvaria, skull base
May 27, 2018 - Epigem’s Managing Director sets the bar for life sciences industry at VentureFest
May 27, 2018 - CPAP may reduce resting heart rate in prediabetic patients
May 27, 2018 - Study reveals striking disparities in health care access and quality across most nations
May 27, 2018 - The Yogi masters were right—meditation and breathing exercises can sharpen your mind
May 27, 2018 - SLU researcher aims to find solutions for diabetes patients at risk of hypoglycemia
May 27, 2018 - Scientists uncover the cause of insulin resistance in obesity
May 27, 2018 - $2.3 million NIH grant to support new project on oxytocin neurons and social behavior
May 27, 2018 - Less Driving Tied to Lower Cardiovascular Disease Risk
May 27, 2018 - Genetics Home Reference: LMNA-related congenital muscular dystrophy
May 27, 2018 - Long-term psychological study confirms time is the best medicine against homesickness
May 27, 2018 - Study explores if CPAP treatment can improve sexual QOL for sleep apnea patients
May 27, 2018 - Study investigates role played by brain in prosocial behavior
May 27, 2018 - New Guidelines Mean 1 in 3 Adults May Need Blood Pressure Meds
May 27, 2018 - Cerebrospinal Fluid (CSF) Analysis: MedlinePlus Lab Test Information
May 27, 2018 - Kids in tough neighborhoods head to ER more often
May 27, 2018 - Exercise alters brain’s dopamine system to help treat addiction, study finds
May 27, 2018 - Sepsis patients treated and released from ED for outpatient follow-up experience good outcomes
May 27, 2018 - Initiative cuts overuse of tests, treatments for bronchiolitis
May 27, 2018 - Study links ‘sleep spindles’ to memory reactivation
May 27, 2018 - Scientists develop new method to speed up genome evolution of baker’s yeast
May 27, 2018 - Sunscreen pills are fake says FDA
May 27, 2018 - Study finds increasing wealth gap between households of seniors and families with children
May 27, 2018 - Link between tuberculosis and Parkinson’s disease discovered
May 27, 2018 - Doctors call on health authorities for permission to provide stroke patients with life-saving treatment
May 26, 2018 - Couples who eat seafood-rich diet tend to get pregnant faster
May 26, 2018 - NIH summit presents recommendations to accelerate treatment development for Alzheimer’s disease
May 26, 2018 - Medication-related harm found to be common among older adults, but preventable
May 26, 2018 - Lunaphore and Vitro announce partnership to develop ISH protocols for RNA, DNA targets
May 26, 2018 - Cryoablation Efficacious for Cancer Pain, Review Finds
May 26, 2018 - Link between IBD and Parkinson’s might allow doctors to slow down condition
May 26, 2018 - Study finds fewer than 5% of low-income, urban mothers use prenatal vitamins before pregnancy
May 26, 2018 - California hospitals urge moms to favor breast milk over formula
May 26, 2018 - Most concussion patients do not receive follow-up care after hospital discharge, says study
May 26, 2018 - Lifetime risks of developing Alzheimer’s dementia vary by age, gender
May 26, 2018 - Researchers find novel ways to improve participation in clinical research
May 26, 2018 - Researchers develop methods for measuring free-base nicotine levels in e-cigarettes
May 26, 2018 - AHA: Preterm Birth Could Warn of Mom’s Future Heart Risks
May 26, 2018 - Some calories more harmful than others
May 26, 2018 - Study links cell size with commitment to division
May 26, 2018 - Researchers develop new, rapid blood test to detect liver damage
May 26, 2018 - Researchers discover cascade of immune processes linked to poor outcomes in aggressive breast cancer
May 26, 2018 - New research will use mathematics to solve mysteries in cell biology
May 26, 2018 - Proposed National Resilience Strategy to reverse catastrophic increases in ‘deaths of despair’
May 26, 2018 - Mice remain slim on burger diet
May 26, 2018 - BMC receives $13.5 million award to test methods for delivering childhood anxiety treatment
May 26, 2018 - ‘Right to Try Act’ will not benefit terminally-ill patients
May 26, 2018 - Study reveals novel statistical algorithm to identify potential disease genes
May 26, 2018 - Two genes play vital roles in malignant brain cancer
May 26, 2018 - Study explores link between groundwater lithium and diagnoses of bipolar disorder, dementia
May 26, 2018 - Researchers reveal stimulatory effects of myelin on young neural cells
May 26, 2018 - Small part of cellular protein that helps form long-term memories also drives neurodegeneration
May 26, 2018 - Four-legged friends can have heart issues, too
May 26, 2018 - Scientists create small, self-contained spaces inside mammalian cells
May 26, 2018 - Better Social Support Network Protects Black Men Against HIV
May 26, 2018 - National Heart, Lung, and Blood Institute (NHLBI)
May 26, 2018 - Burnout, depression can affect ophthalmology residents, study finds
May 26, 2018 - Latinos and African Americans more likely to experience serious depression than Whites
May 26, 2018 - Data from past epidemic could help improve response to future Ebola outbreaks
May 26, 2018 - Researchers provide insight into how the memory molecule limits brain plasticity
May 26, 2018 - OSU biologist describes ‘restoration ecology’ approach toward patient health
May 26, 2018 - New approach to study brown fat could aid in finding treatments for obesity
May 26, 2018 - UCI Center on Stress & Health receives NIH funding to develop digital health interventions
May 26, 2018 - Could More Fish in the Diet Boost Sex Lives and Fertility?
May 26, 2018 - NTU Singapore and SERI invent new scope to diagnose glaucoma
Innovative research could lead to new ways to treat, prevent cancer

Innovative research could lead to new ways to treat, prevent cancer

image_pdfDownload PDFimage_print

Research into cancer can provide new insight into how this disease works and how it can be stopped. The Experimental Biology 2018 meeting (EB 2018) will showcase innovative research that could lead to new ways to treat and prevent cancer.

Potential treatment for pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC), which makes up 90 percent of all pancreatic cancers, has a 5-year survival rate of less than five percent. The cancer is not only difficult to detect but treatment is often complicated by mutations in the p53 tumor suppressor gene that make the cancer cells resistant to chemotherapy. Researchers from the Human BioMolecular Research Institute, University of California San Diego and ChemRegen, Inc. developed a new compound that could be useful for treating pancreatic cancer. They previously showed that the compound killed PDAC cells with and without mutant p53 and strongly inhibited tumor growth in an invasive PDAC tumor mouse model. In new work, the researchers showed that the compound works by uniquely targeting two human cell death pathways: programmed cell death, or apoptosis, and the intracellular degradation system known as autophagy. They also showed that the compound’s potency comes from its ability to induce crosstalk between PDAC cell death pathways.

Jiongjia Cheng will present this research at the American Society for Pharmacology and Experimental Therapeutics (ASPET) annual meeting from 12:302:30 p.m. Tuesday, April 24, in Exhibit Halls A-D (poster C197) (abstract).

Insights into chemotherapy-associated pain

Patients receiving anti-cancer drugs often experience debilitating pain because of a condition known as chemotherapy-induced peripheral neuropathy. Scientists don’t fully understand why the drugs cause this condition, which currently has no treatment. In a new study, researchers from the University of Texas Health Science Center at San Antonio discovered that exposure to vinca alkaloids and taxanes chemotherapy drugs was associated with an immediate pain response activated through the peripheral nerves that detect pain stimuli. Their experiments revealed that the chemotherapy drugs cause overexcitation of sensory neurons by specifically activating the an ion channel (TrpA1) involved in pain perception. The study represents the first demonstration of direct activation of sensory neurons by anti-cancer drugs and supports a role for TrpA1 in the development of chemotherapy-induced peripheral neuropathy. The findings could lead to new treatments for pain associated with chemotherapy drugs.

Nina Boiko will present this research at the American Physiological Society annual meeting from 78:30 p.m. Saturday, April 21, in the Sails Pavilion (poster SH16) (abstract); from 9:4510 a.m. Monday, April 23, in Room 25C; and from 10 a.m.–noon Monday, April 23, in the Exhibit Hall (poster A518).

Highly potent NSAID inhibits colon cancer

Indomethacin is a highly potent nonsteroidal anti-inflammatory drug (NSAID) that has shown anticancer properties in people and animal models. To find out if this drug inhibits colon cancer, researchers from University of Texas Health Sciences Center in Houston conducted a study involving unmodified indomethacin and indomethacin modified with phosphatidylcholine to protect against NSAID injury in the gastrointestinal tract. In cultured cancer cells from mice, doses of both indomethacin formulations significantly inhibited colon cancer cell growth in culture, with the phosphatidylcholine formulation showing slightly more potency at the lowest dose tested. Similarly, in mice injected with colon cancer cells, treatment with both forms of indomethacin brought significant reductions in the number of tumors compared to mice receiving no treatment. The researchers conclude that indomethacin and phosphatidylcholine-indomethacin are strong and effective inhibitors of colon cancer cell growth and hold potential for preventing, and possibly treating, colorectal cancer in people.

Lenard Lichtenberger will present this research at the ASPET annual meeting from 12:30 p.m.2 p.m. Monday, April 23, in Exhibit Halls A-D (poster C243 701.9) (abstract).

Understanding what drives breast cancer growth

Cold-inducible RNA binding protein (CIRP) plays an important role in regulating gene expression and how cells respond to stress. To better understand CIRP’s role in breast cancer, researchers from the University of New Mexico Health Sciences Center are studying a mouse model of breast cancer that expresses CIRP at levels that are higher than normal. The researchers report that the increased levels of CIRP inhibited growth, progression and metastasis of tumors. These anti-cancer effects were associated with changes in immune system signals known as cytokines. Specifically, the mice exhibited decreased levels of cytokines that promote an environment favorable for tumor growth and increased levels of cytokines that create an antitumorigenic environment. The researchers continue to study the mechanisms involved in CIRP’s ability to influence signaling between cancer and immune cells so that this information could be used to improve standard therapies and immunotherapeutic approaches for treating breast cancer.

Daniel Lujan will present this research at the American Association of Anatomists annual meeting during the Cell Biology Award Hybrid Symposium at 11:30 a.m. Sunday, April 22, in Room 11A (abstract).

Tagged with:

About author

Related Articles